{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T06:41:52Z","timestamp":1791009712613,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":1918,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1097\/jto.0b013e3181e96e30","type":"journal-article","created":{"date-parts":[[2010,7,22]],"date-time":"2010-07-22T09:44:36Z","timestamp":1279791876000},"page":"1447-1453","source":"Crossref","is-referenced-by-count":60,"title":["Expression and Mutational Status of c-kit in Thymic Epithelial Tumors"],"prefix":"10.1016","volume":"5","author":[{"given":"Iacopo","family":"Petrini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo A.","family":"Zucali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Seung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marbin A.","family":"Pineda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul S.","family":"Meltzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Walter-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Roncalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yisong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Giaccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/JTO.0b013e3181e96e30_bib1","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/ijc.11099","article-title":"Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignancies","volume":"105","author":"Engels","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1097\/JTO.0b013e3181e96e30_bib2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/jso.10231","article-title":"Clinical spectrum of primary mediastinal tumors: a comparison of adult and pediatric populations at a single Japanese institution","volume":"83","author":"Takeda","year":"2003","journal-title":"J Surg Oncol"},{"key":"10.1097\/JTO.0b013e3181e96e30_bib3","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/cncr.10226","article-title":"The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients","volume":"94","author":"Okumura","year":"2002","journal-title":"Cancer"},{"key":"10.1097\/JTO.0b013e3181e96e30_bib4","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11864-009-0083-7","article-title":"Treatment of advanced thymoma and thymic carcinoma","volume":"9","author":"Rajan","year":"2008","journal-title":"Curr Treat Options Oncol"},{"key":"10.1097\/JTO.0b013e3181e96e30_bib5","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/j.biocel.2006.12.005","article-title":"c-Kit\u2014a hematopoietic cell essential receptor tyrosine kinase","volume":"39","author":"Edling","year":"2007","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1097\/JTO.0b013e3181e96e30_bib6","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1200\/JCO.2004.05.140","article-title":"Biology of gastrointestinal stromal tumors","volume":"22","author":"Corless","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e3181e96e30_bib7","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1309\/A7M2XTMJQK0KPQER","article-title":"Overexpression of KIT (CD117) in chromophobe renal cell carcinoma and renal oncocytoma","volume":"121","author":"Pan","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"10.1097\/JTO.0b013e3181e96e30_bib8","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/sj.leu.2402341","article-title":"Abnormality of c-kit oncoprotein in certain patients with chronic myelogenous leukemia\u2014potential clinical significance","volume":"16","author":"Inokuchi","year":"2002","journal-title":"Leukemia"},{"key":"10.1097\/JTO.0b013e3181e96e30_bib9","doi-asserted-by":"crossref","first-page":"4342","DOI":"10.1200\/JCO.2003.04.190","article-title":"Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor","volume":"21","author":"Heinrich","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e3181e96e30_bib10","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/00000478-200407000-00007","article-title":"KIT-negative gastrointestinal stromal tumors: proof of concept and therapeutic implications","volume":"28","author":"Medeiros","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1097\/JTO.0b013e3181e96e30_bib11","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00280-002-0564-x","article-title":"Response to imatinib mesylate of a gastrointestinal stromal tumor with very low expression of KIT","volume":"51","author":"Bauer","year":"2003","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1097\/JTO.0b013e3181e96e30_bib12","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s00432-004-0545-z","article-title":"Tyrosine kinase receptor expression in thymomas","volume":"130","author":"Henley","year":"2004","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1097\/JTO.0b013e3181e96e30_bib13","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1378\/chest.128.1.140","article-title":"Immunohistochemical KIT (CD117) expression in thymic epithelial tumors","volume":"128","author":"Nakagawa","year":"2005","journal-title":"Chest"},{"key":"10.1097\/JTO.0b013e3181e96e30_bib14","doi-asserted-by":"crossref","first-page":"6790","DOI":"10.1158\/1078-0432.CCR-09-0644","article-title":"Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas and thymomas","volume":"15","author":"Girard","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1097\/JTO.0b013e3181e96e30_bib15","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.lungcan.2008.03.013","article-title":"Mutational status of EGFR and KIT in thymoma and thymic carcinoma","volume":"62","author":"Yoh","year":"2008","journal-title":"Lung Cancer"},{"key":"10.1097\/JTO.0b013e3181e96e30_bib16","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.lungcan.2008.03.035","article-title":"Absence of gene mutations in KIT-positive thymic epithelial tumors","volume":"62","author":"Tsuchida","year":"2008","journal-title":"Lung Cancer"},{"key":"10.1097\/JTO.0b013e3181e96e30_bib17","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1056\/NEJM200406173502523","article-title":"Thymic carcinoma with overexpression of mutated KIT and the response to imatinib","volume":"350","author":"Strobel","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1097\/JTO.0b013e3181e96e30_bib18","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/JTO.0b013e3181a52e25","article-title":"Long lasting response to the multikinase inhibitor bay 43\u20139006 (Sorafenib) in a heavily pretreated metastatic thymic carcinoma","volume":"4","author":"Bisagni","year":"2009","journal-title":"J Thorac Oncol"},{"key":"10.1097\/JTO.0b013e3181e96e30_bib19","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.1158\/0008-5472.CAN-04-1443","article-title":"BAY 43\u20139006 exhibits broad spectrum oral antitumor activity and targets the RAF\/MEK\/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis","volume":"64","author":"Wilhelm","year":"2004","journal-title":"Cancer Res"},{"key":"10.1097\/JTO.0b013e3181e96e30_bib20","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1097\/JTO.0b013e3181b6be57","article-title":"Imatinib mesylate in patients with WHO B3 thymomas and thymic carcinomas","volume":"4","author":"Giaccone","year":"2009","journal-title":"J Thoracic Oncol"},{"key":"10.1097\/JTO.0b013e3181e96e30_bib21","doi-asserted-by":"crossref","first-page":"8116","DOI":"10.1200\/jco.2008.26.15_suppl.8116","article-title":"Imatinib for the treatment of thymic carcinoma","volume":"26","author":"Salter","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e3181e96e30_bib22","series-title":"Tumors of the Lung, Pleura, Thymus and Heart, World Health Organization Classification of Tumours","first-page":"146","author":"Muller-Hermelink","year":"2004"},{"key":"10.1097\/JTO.0b013e3181e96e30_bib23","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/1010-7940(94)90155-4","article-title":"Thymectomy and malignancy","volume":"8","author":"Masaoka","year":"1994","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1097\/JTO.0b013e3181e96e30_bib24","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1200\/JCO.2004.10.113","article-title":"Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis","volume":"22","author":"Strobel","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e3181e96e30_bib25","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1002\/ijc.23335","article-title":"Establishment, characterization and drug sensitivity testing in primary cultures of human thymoma and thymic carcinoma","volume":"122","author":"Ehemann","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1097\/JTO.0b013e3181e96e30_bib26","first-page":"8624","article-title":"Gastrointestinal stromal tumors with KIT mutations exhibit a remarkably homogeneous gene expression profile","volume":"61","author":"Allander","year":"2001","journal-title":"Cancer Res"},{"key":"10.1097\/JTO.0b013e3181e96e30_bib27","first-page":"271","article-title":"Treatment monitoring with (18)F-FDG PET in metastatic thymoma after (90)Y-Dotatoc and selective internal radiation treatment (SIRT)","volume":"12","author":"Vasamiliette","year":"2009","journal-title":"Hell J Nucl Med"},{"key":"10.1097\/JTO.0b013e3181e96e30_bib28","first-page":"6139","article-title":"Expression of c-kit receptor in normal and transformed human nonlymphoid tissues","volume":"52","author":"Natali","year":"1992","journal-title":"Cancer Res"},{"key":"10.1097\/JTO.0b013e3181e96e30_bib29","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/ijc.20252","article-title":"Expression of the tyrosine kinase c-kit is an independent prognostic factor in patients with small cell lung cancer","volume":"111","author":"Rohr","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1097\/JTO.0b013e3181e96e30_bib30","first-page":"2241","article-title":"Expression and prognostic significance of kit, protein kinase B, and mitogen-activated protein kinase in patients with small cell lung cancer","volume":"9","author":"Blackhall","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1097\/JTO.0b013e3181e96e30_bib31","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/cncr.10665","article-title":"New WHO histologic classification predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymoma cases from China","volume":"95","author":"Chen","year":"2002","journal-title":"Cancer"},{"key":"10.1097\/JTO.0b013e3181e96e30_bib32","doi-asserted-by":"crossref","first-page":"6862","DOI":"10.1158\/1078-0432.CCR-09-1315","article-title":"Mechanisms of sunitinib resistance in gastrointestinal stromal tumors harboring KITAY502\u20133ins mutation: an in vitro mutagenesis screen for drug resistance","volume":"15","author":"Guo","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1097\/JTO.0b013e3181e96e30_bib33","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00535-005-1674-0","article-title":"Pathophysiology, diagnosis, and treatment of gastrointestinal stromal tumors","volume":"40","author":"Shinomura","year":"2005","journal-title":"J Gastroenterol"},{"key":"10.1097\/JTO.0b013e3181e96e30_bib34","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1158\/1535-7163.MCT-09-0662","article-title":"Activate and resist: L576P-KIT in GIST","volume":"8","author":"Conca","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"10.1097\/JTO.0b013e3181e96e30_bib35","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/path.1514","article-title":"KIT (CD117) is frequently overexpressed in thymic carcinomas but is absent in thymomas","volume":"202","author":"Pan","year":"2004","journal-title":"J Pathol"},{"key":"10.1097\/JTO.0b013e3181e96e30_bib36","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s12032-008-9100-0","article-title":"Response to sorafenib in cisplatin-resistant thymic carcinoma: a case report","volume":"26","author":"Li","year":"2009","journal-title":"Med Oncol"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415306237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415306237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,7]],"date-time":"2020-06-07T09:30:47Z","timestamp":1591522247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086415306237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S1556086415306237"],"URL":"https:\/\/doi.org\/10.1097\/jto.0b013e3181e96e30","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}